<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00499941</url>
  </required_header>
  <id_info>
    <org_study_id>HR 9059</org_study_id>
    <nct_id>NCT00499941</nct_id>
  </id_info>
  <brief_title>Alpha-1 Foundation Research Registry</brief_title>
  <official_title>Alpha-1 Foundation Research Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alpha-1 Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Alpha-1 Foundation Research Registry is a confidential database made up of individuals
      diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Registry was established in 1997 by the Alpha-1 Foundation to facilitate research
      initiatives and promote the development of improved treatments and a cure for Alpha-1.
      Located at the Medical University of South Carolina (MUSC) in Charleston, the Registry
      employs procedures that ensure the most stringent confidentiality of participants. The
      Registry operates under the direction of the Alpha-1 Foundation Board of Directors and is
      guided by an Advisory Committee comprised of leaders in the medical, ethical, scientific and
      Alpha communities. Individuals enrolled in the Registry have the ongoing opportunity to
      participate directly in clinical trials of new therapeutic approaches in addition to other
      research opportunities.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2000</start_date>
  <completion_date type="Anticipated">June 2050</completion_date>
  <primary_completion_date type="Anticipated">June 2050</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>To study the natural history of PiZZ, PiSZ, and PiMZ alpha-1 antitrypsin deficiency</measure>
    <time_frame>Not limited</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Alpha 1-Antitrypsin Deficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals of all ages who are diagnosed with severe alpha-1 antitrypsin deficiency or the
        carrier state
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals of all ages who are diagnosed with severe alpha-1 antitrypsin deficiency
             or the carrier state
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charlie Strange, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlie Strange, M.D.</last_name>
    <phone>843-792-1219</phone>
    <email>alphaone@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charlie Strange, MD</last_name>
    <phone>843-792-3174</phone>
    <email>strangec@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlie Strange, M.D.</last_name>
      <phone>843-792-1219</phone>
      <email>alphaone@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Charlie Strange, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.alphaoneregistry.org</url>
    <description>Alpha-1 Foundation Research Registry Website</description>
  </link>
  <reference>
    <citation>Williams PH, Shore L, Sineath M, Quill J, Warner B, Keith J, Walker D, Wienke S, Flavin S, Strange C. Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiency. Nurs Clin North Am. 2013 Dec;48(4):627-36. doi: 10.1016/j.cnur.2013.09.008.</citation>
    <PMID>24295190</PMID>
  </reference>
  <reference>
    <citation>Smith RA, Wienke S, Coffman DL. Alpha-1 couples: interpersonal and intrapersonal predictors of spousal communication and stress. J Genet Couns. 2014 Apr;23(2):212-20. doi: 10.1007/s10897-013-9639-6. Epub 2013 Aug 11.</citation>
    <PMID>23934327</PMID>
  </reference>
  <reference>
    <citation>Smith RA, Wienke SE, Baker MK. Classifying married adults diagnosed with alpha-1 antitrypsin deficiency based on spousal communication patterns using latent class analysis: insights for intervention. J Genet Couns. 2014 Jun;23(3):299-310. doi: 10.1007/s10897-013-9661-8. Epub 2013 Nov 1.</citation>
    <PMID>24177906</PMID>
  </reference>
  <reference>
    <citation>Holm KE, Wamboldt FS, Ford DW, Sandhaus RA, Strand M, Strange C, Hoth KF. The prospective association of perceived criticism with dyspnea in chronic lung disease. J Psychosom Res. 2013 May;74(5):450-3. doi: 10.1016/j.jpsychores.2013.02.001. Epub 2013 Feb 28.</citation>
    <PMID>23597335</PMID>
  </reference>
  <reference>
    <citation>Holm KE, Borson S, Sandhaus RA, Ford DW, Strange C, Bowler RP, Make BJ, Wamboldt FS. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD. COPD. 2013 Apr;10(2):226-34. doi: 10.3109/15412555.2012.719049.</citation>
    <PMID>23547634</PMID>
  </reference>
  <reference>
    <citation>Hoth KF, Wamboldt FS, Strand M, Ford DW, Sandhaus RA, Strange C, Bekelman DB, Holm KE. Prospective impact of illness uncertainty on outcomes in chronic lung disease. Health Psychol. 2013 Nov;32(11):1170-4. doi: 10.1037/a0032721. Epub 2013 Jun 17.</citation>
    <PMID>23772888</PMID>
  </reference>
  <reference>
    <citation>Hoth KF, Ford DW, Sandhaus RA, Strange C, Wamboldt FS, Holm KE. Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD. COPD. 2012 Aug;9(4):417-25. doi: 10.3109/15412555.2012.684414. Epub 2012 May 31.</citation>
    <PMID>22651849</PMID>
  </reference>
  <results_reference>
    <citation>Stoller JK, Brantly M, Fleming LE, Bean JA, Walsh J. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency. Chest. 2000 Sep;118(3):843-8.</citation>
    <PMID>10988213</PMID>
  </results_reference>
  <results_reference>
    <citation>Bowlus CL, Willner I, Zern MA, Reuben A, Chen P, Holladay B, Xie L, Woolson RF, Strange C. Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol. 2005 Apr;3(4):390-6.</citation>
    <PMID>15822045</PMID>
  </results_reference>
  <results_reference>
    <citation>Eden E, Strange C, Holladay B, Xie L. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med. 2006 Aug;100(8):1384-91. Epub 2006 Jan 5.</citation>
    <PMID>16403617</PMID>
  </results_reference>
  <results_reference>
    <citation>McGee D, Strange C, McClure R, Schwarz L, Erven M. The Alpha-1 Association Genetic Counseling Program: an innovative approach to service. J Genet Couns. 2011 Aug;20(4):330-6. doi: 10.1007/s10897-011-9355-z. Epub 2011 Mar 19.</citation>
    <PMID>21424325</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2007</study_first_submitted>
  <study_first_submitted_qc>July 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2007</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Charlie Strange</investigator_full_name>
    <investigator_title>Professor of Pulmonary and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Alpha 1-Antitrypsin Deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data sharing is encouraged by coordinator contact at MUSC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

